ArcKR expression modifies synaptic plasticity following epileptic activity: Differential effects with in vitro and in vivo seizure‐induction protocols
Epilepsia · 2024
DOI: 10.1111/epi.17981 ↗Kurz gefasst
Fachartikel in der Zeitschrift Epilepsia, 2024. Verfasst von Amol Bhandare und 6 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Sciences, University of Warwick, Coventry, UK. Hauptthemen laut MEDLINE: Neuronal Plasticity, Hippocampus, Mice, Transgenic, Kainic Acid. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: European Erasmus+ Exchange Program.
Abstract (Originalsprache)
Objectives
Pathological forms of neural activity, such as epileptic seizures, modify the expression pattern of multiple proteins, leading to persistent changes in brain function. One such protein is activity‐regulated cytoskeleton‐associated protein (Arc), which is critically involved in protein‐synthesis–dependent synaptic plasticity underlying learning and memory. In the present study, we have investigated how the expression of ArcKR, a form of Arc in which the ubiquitination sites have been mutated, resulting in slowed Arc degradation, modifies group I metabotropic glutamate receptor–mediated long‐term depression (G1‐mGluR‐LTD) following seizures.
Methods
We used a knock‐in mice line that express ArcKR and two hyperexcitation models: an in vitro model, where hippocampal slices were exposed to zero Mg 2+ , 6 mM K + ; and an in vivo model, where kainic acid was injected unilaterally into the hippocampus. In both models, field excitatory postsynaptic potentials (fEPSPs) were recorded from the CA1 region of hippocampal slices in response to Schaffer collateral stimulation and G1‐mGluR‐LTD was induced chemically with the group 1 mGluR agonist DHPG.
Results
In the in vitro model, ArcKR expression enhanced the effects of seizure activity and increased the magnitude of G1‐mGluR LTD, an effect that could be blocked with the mGluR5 antagonist MTEP. In the in vivo model, fEPSPs were significantly smaller in slices from ArcKR mice and were less contaminated by population spikes. In this model, the amount of G1‐mGluR‐LTD was significantly less in epileptic slices from ArcKR mice as compared to wildtype (WT) mice. Significance We have shown that expression of ArcKR, a form of Arc in which degradation is reduced, significantly modulates the magnitude of G1‐mGluR‐LTD following epileptic seizures. However, the effect of ArcKR on LTD depends on the epileptic model used, with enhancement of LTD in an in vitro model and a reduction in the kainate mouse model.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Life Sciences, University of Warwick, Coventry, UK.
- Bradford School of Pharmacy and Medical Sciences, University of Bradford, Bradford, UK.
- Department of Life Sciences, Faculty of Science and Engineering, Manchester Metropolitan University, Manchester, UK.
ORCID-Profile: Luana B Domingos, Sonia A L Corrêa, Mark J Wall
Förderung
- European Erasmus+ Exchange Program
Zitieren
APA
Bhandare, A., Haley, M., Torrico Anderson, V., Domingos, L. B., Lopes, M., Corrêa, S. A. L., & Wall, M. J. (2024). ArcKR expression modifies synaptic plasticity following epileptic activity: Differential effects with in vitro and in vivo seizure‐induction protocols. Epilepsia. https://doi.org/10.1111/epi.17981
Vancouver
Bhandare A, Haley M, Torrico Anderson V, Domingos LB, Lopes M, Corrêa SAL, et al. ArcKR expression modifies synaptic plasticity following epileptic activity: Differential effects with in vitro and in vivo seizure‐induction protocols. Epilepsia. 2024. doi:10.1111/epi.17981
BibTeX
@article{Bhandare2024,
author = {Bhandare, Amol and Haley, Maisy and Torrico Anderson, Vanessa and Domingos, Luana B and Lopes, Marcia and Corrêa, Sonia A L and Wall, Mark J},
title = {ArcKR expression modifies synaptic plasticity following epileptic activity: Differential effects with in vitro and in vivo seizure‐induction protocols},
journal = {Epilepsia},
year = {2024},
doi = {10.1111/epi.17981}
}
EUVIMED